title: Evaluating non-adherence to immunosuppressant medications in pediatric liver transplant recipients.
abstract: Non-adherence with recommended immunosuppressant medications is common post-pediatric liver transplant and is the most important reason for organ rejection in long-term survivors. However, there is currently no validated, standard method to measure adherence, with a well-defined threshold, making it extremely difficult to evaluate interventions to improve adherence. Previous studies have suggested that the degree of fluctuation of medication blood levels over time can provide an idea about how regularly the medication is being taken. The present study, conducted at UCLA medical center, sought to identify a specific threshold value of the s.d. of individual tacrolimus blood levels in pediatric liver transplant recipients which would be associated with rejection episodes in these patients. A threshold of 3.0 has been identified in other studies, and was supported by the analysis of retrospective data from 96 subjects. However, further analysis found that a s.d. of 2.5 appeared to have a better fit with the data. These findings suggest the utility of monitoring the s.d. of routine tacrolimus blood levels in pediatric liver transplant recipients for detecting non-adherence to immunosuppressant medication prior to clinical rejection, allowing earlier interventions.
authors.affiliation: Mattel Children's Hospital, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. mstuber@mednet.ulca.edu
authors.forename: Margaret L
authors.initials: ML
authors.lastname: Stuber
authors.forename: Eyal
authors.initials: E
authors.lastname: Shemesh
authors.forename: Debra
authors.initials: D
authors.lastname: Seacord
authors.forename: James
authors.initials: J
authors.lastname: Washington
authors.forename: Gerhard
authors.initials: G
authors.lastname: Hellemann
authors.forename: Susan
authors.initials: S
authors.lastname: McDiarmid
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007223:Infant; D007231:Infant, Newborn; D016031:Liver Transplantation / Q000379:methods*; D008297:Male; D010349:Patient Compliance; D010372:Pediatrics / Q000379:methods; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus